mutation predictions | marginal predictions | summary statistics | genome diff | command line log
|
breseq version 0.33.1 revision 8505477f25b3
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
| Predicted mutations | |||||||
|---|---|---|---|---|---|---|---|
| evidence | seq id | position | mutation | freq | annotation | gene | description |
| RA | CP000731 | 81 | N→G | 100% | intergenic (–/‑151) | – / → repA | –/replication protein A |
| JC | CP000731 | 6,552 | +28 bp | 100% | intergenic (+1069/‑419) | cadX → / → USA300HOU_pUSA300HOUMR0010 | cadmium efflux regulator/MarR family transcriptional regulator |
| RA | CP000731 | 12,012 | A→G | 5.4% | intergenic (+175/+48) | USA300HOU_pUSA300HOUMR0014 → / ← USA300HOU_pUSA300HOUMR0015 | recombinase/hypothetical protein |
| RA | CP000731 | 25,663 | Δ1 bp | 100% | coding (316/333 nt) | USA300HOU_pUSA300HOUMR0031 → | hypothetical protein |
| RA | USA300TCH1516_ALE | 9,710 | T→C | 7.3% | intergenic (+15/+72) | gyrA → / ← nnrD | DNA gyrase subunit A/ADP‑dependent (S)‑NAD(P)H‑hydrate dehydratase |
| RA | USA300TCH1516_ALE | 9,716 | T→C | 6.7% | intergenic (+21/+66) | gyrA → / ← nnrD | DNA gyrase subunit A/ADP‑dependent (S)‑NAD(P)H‑hydrate dehydratase |
| RA | USA300TCH1516_ALE | 9,719 | G→A | 6.0% | intergenic (+24/+63) | gyrA → / ← nnrD | DNA gyrase subunit A/ADP‑dependent (S)‑NAD(P)H‑hydrate dehydratase |
| RA | USA300TCH1516_ALE | 9,725 | G→A | 6.0% | intergenic (+30/+57) | gyrA → / ← nnrD | DNA gyrase subunit A/ADP‑dependent (S)‑NAD(P)H‑hydrate dehydratase |
| RA | USA300TCH1516_ALE | 18,223 | G→A | 5.1% | V273I (GTT→ATT) | USA300HOU_RS00065 → | hypothetical protein |
| RA | USA300TCH1516_ALE | 61,741 | C→T | 6.4% | E265K (GAA→AAA) | USA300TCH1516_00053 ← | hypothetical protein |
| JC | USA300TCH1516_ALE | 62,817 | +TCAATT | 100% | intergenic (‑284/+229) | USA300TCH1516_00053 ← / ← speG | hypothetical protein/Spermidine N(1)‑acetyltransferase |
| RA | USA300TCH1516_ALE | 70,101 | A→T | 5.0% | I228N (ATT→AAT) | argF_1 ← | Ornithine carbamoyltransferase |
| RA | USA300TCH1516_ALE | 90,248 | Δ1 bp | 5.8% | coding (857/870 nt) | USA300TCH1516_00080 → | hypothetical protein |
| RA | USA300TCH1516_ALE | 90,249 | Δ1 bp | 5.8% | coding (858/870 nt) | USA300TCH1516_00080 → | hypothetical protein |
| RA | USA300TCH1516_ALE | 99,276 | G→C | 5.8% | intergenic (+70/+2) | USA300HOU_RS00465 → / ← tetA_1 | hypothetical protein/Tetracycline resistance protein, class C |
| RA | USA300TCH1516_ALE | 109,522 | G→A | 6.2% | T196T (ACG→ACA) | plc → | 1‑phosphatidylinositol phosphodiesterase |
| RA | USA300TCH1516_ALE | 109,531 | A→G | 5.4% | K199K (AAA→AAG) | plc → | 1‑phosphatidylinositol phosphodiesterase |
| RA | USA300TCH1516_ALE | 109,964 | T→A | 5.1% | intergenic (+43/‑178) | plc → / → USA300HOU_RS00515 | 1‑phosphatidylinositol phosphodiesterase/putative lipoprotein |
| RA | USA300TCH1516_ALE | 110,651 | C→T | 9.2% | D170D (GAC→GAT) | USA300HOU_RS00515 → | putative lipoprotein |
| RA | USA300TCH1516_ALE | 110,660 | T→A | 15.2% | I173I (ATT→ATA) | USA300HOU_RS00515 → | putative lipoprotein |
| RA | USA300TCH1516_ALE | 111,512 | A→G | 27.9% | S194S (TCA→TCG) | USA300HOU_RS00520 → | putative lipoprotein |
| RA | USA300TCH1516_ALE | 111,516 | C→A | 29.3% | Q196K (CAA→AAA) | USA300HOU_RS00520 → | putative lipoprotein |
| RA | USA300TCH1516_ALE | 111,560 | T→C | 8.9% | R210R (CGT→CGC) | USA300HOU_RS00520 → | putative lipoprotein |
| RA | USA300TCH1516_ALE | 124,550 | G→A | 6.1% | D229N (GAT→AAT) | norG → | HTH‑type transcriptional regulator NorG |
| RA | USA300TCH1516_ALE | 153,657 | T→C | 6.6% | A420A (GCT→GCC) | rfbX → | Putative O‑antigen transporter |
| RA | USA300TCH1516_ALE | 168,354 | C→G | 5.1% | intergenic (+321/+27) | yfkN_1 → / ← USA300TCH1516_00148 | Trifunctional nucleotide phosphoesterase protein YfkN/hypothetical protein |
| RA | USA300TCH1516_ALE | 178,248 | T→G | 5.3% | Y75D (TAT→GAT) | capD → | UDP‑glucose 4‑epimerase |
| RA | USA300TCH1516_ALE | 182,889 | C→T | 5.7% | L318L (CTA→TTA) | glgA → | Glycogen synthase |
| RA | USA300TCH1516_ALE | 183,887 | C→A | 8.5% | P276Q (CCG→CAG) | USA300HOU_RS00845 → | hypothetical protein |
| RA | USA300TCH1516_ALE | 211,512 | T→A | 5.2% | intergenic (+70/+258) | sfp → / ← yagU | 4'‑phosphopantetheinyl transferase sfp/Inner membrane protein YagU |
| RA | USA300TCH1516_ALE | 220,088 | A→T | 5.2% | G289G (GGT→GGA) | ipdC ← | Indole‑3‑pyruvate decarboxylase |
| RA | USA300TCH1516_ALE | 225,063 | T→A | 5.3% | I50I (ATT→ATA) | murQ → | N‑acetylmuramic acid 6‑phosphate etherase |
| RA | USA300TCH1516_ALE | 238,173 | T→C | 5.3% | I58I (ATT→ATC) | gsiD_2 → | Glutathione transport system permease protein GsiD |
| RA | USA300TCH1516_ALE | 264,043 | C→T | 5.5% | P69P (CCC→CCT) | ugpQ_2 → | Glycerophosphodiester phosphodiesterase, cytoplasmic |
| RA | USA300TCH1516_ALE | 267,167 | G→A | 6.0% | T290T (ACG→ACA) | USA300HOU_RS01175 → | Staphylocoagulase |
| RA | USA300TCH1516_ALE | 267,872 | T→C | 6.2% | R525R (CGT→CGC) | USA300HOU_RS01175 → | Staphylocoagulase |
| RA | USA300TCH1516_ALE | 267,908 | T→C | 6.9% | Y537Y (TAT→TAC) | USA300HOU_RS01175 → | Staphylocoagulase |
| RA | USA300TCH1516_ALE | 313,483 | C→T | 5.4% | L220L (TTG→TTA) | rebM ← | Demethylrebeccamycin‑D‑glucose O‑methyltransferase |
| RA | USA300TCH1516_ALE | 336,153 | A→G | 5.8% | G97G (GGA→GGG) | essC → | ESAT‑6 secretion machinery protein EssC |
| RA | USA300TCH1516_ALE | 352,096 | G→A | 5.1% | K6K (AAG→AAA) | yezG_10 → | putative antitoxin YezG |
| RA | USA300TCH1516_ALE | 355,692 | G→T | 6.2% | V336V (GTC→GTA) | brnQ_2 ← | Branched‑chain amino acid transport system 2 carrier protein |
| RA | USA300TCH1516_ALE | 355,854 | G→T | 5.8% | I282I (ATC→ATA) | brnQ_2 ← | Branched‑chain amino acid transport system 2 carrier protein |
| RA | USA300TCH1516_ALE | 374,866 | T→C | 5.4% | N196D (AAT→GAT) | USA300HOU_RS01705 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 406,781 | C→A | 6.4% | P293Q (CCA→CAA) | USA300HOU_RS01880 → | putative acetyl‑CoA acyltransferase |
| RA | USA300TCH1516_ALE | 419,854 | G→A | 9.6% | intergenic (+72/+194) | rpsR → / ← USA300HOU_RS01950 | 30S ribosomal protein S18/hypothetical protein |
| RA | USA300TCH1516_ALE | 473,952 | T→C | 5.2% | D83D (GAT→GAC) | USA300HOU_RS02255 → | hypothetical protein |
| RA | USA300TCH1516_ALE | 475,163 | C→T | 5.5% | D159D (GAC→GAT) | yciC_1 → | Putative metal chaperone YciC |
| RA | USA300TCH1516_ALE | 480,623 | G→A | 5.5% | K550K (AAG→AAA) | USA300HOU_RS02280 → | hypothetical protein |
| RA | USA300TCH1516_ALE | 491,299 | G→T | 6.1% | intergenic (+57/‑275) | metQ_1 → / → sle1_1 | putative D‑methionine‑binding lipoprotein MetQ/N‑acetylmuramoyl‑L‑alanine amidase sle1 |
| RA | USA300TCH1516_ALE | 491,302 | G→C | 6.4% | intergenic (+60/‑272) | metQ_1 → / → sle1_1 | putative D‑methionine‑binding lipoprotein MetQ/N‑acetylmuramoyl‑L‑alanine amidase sle1 |
| RA | USA300TCH1516_ALE | 491,332 | T→A | 5.6% | intergenic (+90/‑242) | metQ_1 → / → sle1_1 | putative D‑methionine‑binding lipoprotein MetQ/N‑acetylmuramoyl‑L‑alanine amidase sle1 |
| RA | USA300TCH1516_ALE | 495,185 | T→C | 5.9% | L309L (TTA→TTG) | USA300HOU_RS02365 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 512,643 | A→G | 45.9% | intergenic (+711/‑6052) | recR → / → speA_2 | Recombination protein RecR/Arginine decarboxylase |
| RA | USA300TCH1516_ALE | 543,821 | A→T | 5.9% | L370F (TTA→TTT) | mazG → | Nucleoside triphosphate pyrophosphohydrolase/pyrophosphatase MazG |
| RA | USA300TCH1516_ALE | 613,998 | G→A | 5.1% | S770S (TCG→TCA) | sdrC → | Serine‑aspartate repeat‑containing protein C |
| RA | USA300TCH1516_ALE | 614,094 | T→C | 9.4% | S802S (AGT→AGC) | sdrC → | Serine‑aspartate repeat‑containing protein C |
| RA | USA300TCH1516_ALE | 614,172 | T→C | 9.2% | S828S (AGT→AGC) | sdrC → | Serine‑aspartate repeat‑containing protein C |
| RA | USA300TCH1516_ALE | 618,483 | T→C | 5.4% | D1195D (GAT→GAC) | sdrD → | Serine‑aspartate repeat‑containing protein D |
| RA | USA300TCH1516_ALE | 618,558 | T→C | 8.0% | S1220S (AGT→AGC) | sdrD → | Serine‑aspartate repeat‑containing protein D |
| RA | USA300TCH1516_ALE | 618,750 | G→A | 6.4% | S1284S (TCG→TCA) | sdrD → | Serine‑aspartate repeat‑containing protein D |
| RA | USA300TCH1516_ALE | 618,756 | T→C | 7.3% | S1286S (AGT→AGC) | sdrD → | Serine‑aspartate repeat‑containing protein D |
| RA | USA300TCH1516_ALE | 622,527 | T→C | 6.8% | D1030D (GAT→GAC) | sdrE → | Serine‑aspartate repeat‑containing protein E |
| RA | USA300TCH1516_ALE | 622,533 | T→C | 10.4% | D1032D (GAT→GAC) | sdrE → | Serine‑aspartate repeat‑containing protein E |
| RA | USA300TCH1516_ALE | 632,109 | C→G | 5.0% | V78V (GTC→GTG) | proP → | Proline/betaine transporter |
| RA | USA300TCH1516_ALE | 632,409 | T→A | 5.1% | A178A (GCT→GCA) | proP → | Proline/betaine transporter |
| RA | USA300TCH1516_ALE | 632,475 | C→T | 6.0% | L200L (CTC→CTT) | proP → | Proline/betaine transporter |
| RA | USA300TCH1516_ALE | 657,770 | G→T | 6.3% | V62V (GTG→GTT) | USA300HOU_RS03150 → | hypothetical protein |
| RA | USA300TCH1516_ALE | 657,806 | A→T | 7.6% | A74A (GCA→GCT) | USA300HOU_RS03150 → | hypothetical protein |
| RA | USA300TCH1516_ALE | 657,807 | G→A | 6.1% | G75S (GGT→AGT) | USA300HOU_RS03150 → | hypothetical protein |
| RA | USA300TCH1516_ALE | 732,682 | T→C | 5.1% | Y235Y (TAT→TAC) | USA300HOU_RS03560 → | hypothetical protein |
| RA | USA300TCH1516_ALE | 740,088 | C→A | 6.0% | intergenic (+315/+273) | pitA_1 → / ← sle1_2 | Low‑affinity inorganic phosphate transporter 1/N‑acetylmuramoyl‑L‑alanine amidase sle1 |
| RA | USA300TCH1516_ALE | 748,209 | T→C | 5.2% | A68A (GCT→GCC) | oxyR → | Hydrogen peroxide‑inducible genes activator |
| RA | USA300TCH1516_ALE | 770,855 | A→G | 6.8% | intergenic (+41/‑209) | ybaK → / → glcR | Cys‑tRNA(Pro)/Cys‑tRNA(Cys) deacylase YbaK/HTH‑type transcriptional repressor GlcR |
| RA | USA300TCH1516_ALE | 803,528 | C→T | 5.3% | intergenic (‑228/+42) | USA300HOU_RS03920 ← / ← dtpT | Putative lipid kinase/Di‑/tripeptide transporter |
| RA | USA300TCH1516_ALE | 803,539 | A→G | 6.2% | intergenic (‑239/+31) | USA300HOU_RS03920 ← / ← dtpT | Putative lipid kinase/Di‑/tripeptide transporter |
| RA | USA300TCH1516_ALE | 815,211 | A→T | 5.5% | G185G (GGA→GGT) | yclQ → | putative ABC transporter solute‑binding protein YclQ |
| RA | USA300TCH1516_ALE | 841,492 | T→G | 5.2% | G575G (GGT→GGG) | uvrA → | UvrABC system protein A |
| RA | USA300TCH1516_ALE | 853,045 | A→G | 5.1% | intergenic (+52/+191) | clpP_1 → / ← USA300HOU_RS04170 | ATP‑dependent Clp protease proteolytic subunit/Epimerase family protein |
| RA | USA300TCH1516_ALE | 895,189 | A→G | 7.2% | T70T (ACA→ACG) | metQ_2 → | Methionine‑binding lipoprotein MetQ |
| RA | USA300TCH1516_ALE | 895,207 | C→T | 6.0% | D76D (GAC→GAT) | metQ_2 → | Methionine‑binding lipoprotein MetQ |
| RA | USA300TCH1516_ALE | 895,369 | A→G | 5.3% | A130A (GCA→GCG) | metQ_2 → | Methionine‑binding lipoprotein MetQ |
| RA | USA300TCH1516_ALE | 895,375 | C→T | 5.5% | V132V (GTC→GTT) | metQ_2 → | Methionine‑binding lipoprotein MetQ |
| RA | USA300TCH1516_ALE | 895,408 | T→C | 6.1% | R143R (CGT→CGC) | metQ_2 → | Methionine‑binding lipoprotein MetQ |
| RA | USA300TCH1516_ALE | 913,454 | C→A | 8.6% | G293G (GGC→GGA) | sufB_1 → | FeS cluster assembly protein SufB |
| RA | USA300TCH1516_ALE | 942,221 | T→A | 5.1% | intergenic (‑192/+57) | ptlE ← / ← mnhG1 | Neopentalenolactone D synthase/Na(+)/H(+) antiporter subunit G1 |
| RA | USA300TCH1516_ALE | 950,088 | T→A | 5.4% | intergenic (+82/‑280) | yugI_2 → / → USA300HOU_RS04740 | General stress protein 13/putative oxidoreductase |
| RA | USA300TCH1516_ALE | 950,093 | T→A | 5.6% | intergenic (+87/‑275) | yugI_2 → / → USA300HOU_RS04740 | General stress protein 13/putative oxidoreductase |
| RA | USA300TCH1516_ALE | 950,098 | T→A | 6.1% | intergenic (+92/‑270) | yugI_2 → / → USA300HOU_RS04740 | General stress protein 13/putative oxidoreductase |
| RA | USA300TCH1516_ALE | 985,066 | T→A | 5.6% | intergenic (‑131/‑164) | USA300HOU_RS04870 ← / → fabH | hypothetical protein/3‑oxoacyl‑[acyl‑carrier‑protein] synthase 3 |
| RA | USA300TCH1516_ALE | 985,069 | A→T | 5.6% | intergenic (‑134/‑161) | USA300HOU_RS04870 ← / → fabH | hypothetical protein/3‑oxoacyl‑[acyl‑carrier‑protein] synthase 3 |
| RA | USA300TCH1516_ALE | 1,034,878 | T→A | 5.0% | V67V (GTA→GTT) | USA300TCH1516_00961 ← | Lipoate‑‑protein ligase 1 |
| RA | USA300TCH1516_ALE | 1,034,893 | G→A | 5.2% | H62H (CAC→CAT) | USA300TCH1516_00961 ← | Lipoate‑‑protein ligase 1 |
| RA | USA300TCH1516_ALE | 1,039,416 | A→C | 5.3% | I12I (ATA→ATC) | USA300TCH1516_00965 → | hypothetical protein |
| RA | USA300TCH1516_ALE | 1,039,417 | T→G | 5.3% | L13V (TTA→GTA) | USA300TCH1516_00965 → | hypothetical protein |
| RA | USA300TCH1516_ALE | 1,051,886 | T→G | 7.4% | R101R (CGA→CGC) | sspC ← | Staphostatin B |
| RA | USA300TCH1516_ALE | 1,052,403 | G→A | 5.1% | D335D (GAC→GAT) | sspB ← | Staphopain B |
| RA | USA300TCH1516_ALE | 1,052,436 | G→A | 5.6% | I324I (ATC→ATT) | sspB ← | Staphopain B |
| RA | USA300TCH1516_ALE | 1,072,831 | A→T | 5.8% | G121G (GGT→GGA) | folD ← | Bifunctional protein FolD protein |
| RA | USA300TCH1516_ALE | 1,080,964 | G→A | 5.5% | L232L (TTG→TTA) | purM → | Phosphoribosylformylglycinamidine cyclo‑ligase |
| RA | USA300TCH1516_ALE | 1,104,230 | G→A | 5.5% | A212A (GCG→GCA) | pdhB → | Pyruvate dehydrogenase E1 component subunit beta |
| RA | USA300TCH1516_ALE | 1,190,794 | A→G | 6.9% | A167A (GCA→GCG) | mraY → | Phospho‑N‑acetylmuramoyl‑pentapeptide‑ transferase |
| RA | USA300TCH1516_ALE | 1,191,016 | C→G | 6.5% | T241T (ACC→ACG) | mraY → | Phospho‑N‑acetylmuramoyl‑pentapeptide‑ transferase |
| RA | USA300TCH1516_ALE | 1,199,472 | G→A | 5.3% | Q39Q (CAG→CAA) | USA300HOU_RS05985 → | hypothetical protein |
| RA | USA300TCH1516_ALE | 1,206,089 | C→A | 5.4% | I134I (ATC→ATA) | lspA → | Lipoprotein signal peptidase |
| RA | USA300TCH1516_ALE | 1,218,734 | A→C | 5.1% | intergenic (+225/+38) | USA300HOU_RS06065 → / ← USA300HOU_RS06070 | hypothetical protein/hypothetical protein |
| RA | USA300TCH1516_ALE | 1,231,411 | A→G | 5.7% | D19G (GAT→GGT) | stp → | Serine/threonine phosphatase stp |
| RA | USA300TCH1516_ALE | 1,250,301 | C→G | 6.6% | T24R (ACA→AGA) | ftsY → | Signal recognition particle receptor FtsY |
| RA | USA300TCH1516_ALE | 1,250,361 | C→T | 6.1% | A44V (GCA→GTA) | ftsY → | Signal recognition particle receptor FtsY |
| RA | USA300TCH1516_ALE | 1,270,066 | A→T | 5.6% | T375T (ACA→ACT) | trmFO → | Methylenetetrahydrofolate‑‑tRNA‑(uracil‑5‑)‑ methyltransferase TrmFO |
| RA | USA300TCH1516_ALE | 1,299,677 | C→T | 5.2% | G446G (GGC→GGT) | rnj2 → | Ribonuclease J 2 |
| RA | USA300TCH1516_ALE | 1,299,755 | T→A | 6.4% | V472V (GTT→GTA) | rnj2 → | Ribonuclease J 2 |
| RA | USA300TCH1516_ALE | 1,306,583 | C→T | 7.6% | P216S (CCA→TCA) | phaB → | Acetoacetyl‑CoA reductase |
| RA | USA300TCH1516_ALE | 1,306,597 | T→C | 6.2% | S220S (AGT→AGC) | phaB → | Acetoacetyl‑CoA reductase |
| RA | USA300TCH1516_ALE | 1,310,096 | G→A | 6.4% | intergenic (+121/‑44) | cinA → / → recA | Putative competence‑damage inducible protein/Protein RecA |
| RA | USA300TCH1516_ALE | 1,315,615 | C→T | 5.5% | T299T (ACC→ACT) | korA → | 2‑oxoglutarate oxidoreductase subunit KorA |
| RA | USA300TCH1516_ALE | 1,315,711 | T→A | 7.0% | I331I (ATT→ATA) | korA → | 2‑oxoglutarate oxidoreductase subunit KorA |
| RA | USA300TCH1516_ALE | 1,315,726 | A→T | 6.8% | T336T (ACA→ACT) | korA → | 2‑oxoglutarate oxidoreductase subunit KorA |
| RA | USA300TCH1516_ALE | 1,315,762 | A→C | 7.5% | A348A (GCA→GCC) | korA → | 2‑oxoglutarate oxidoreductase subunit KorA |
| RA | USA300TCH1516_ALE | 1,315,802 | C→T | 5.1% | L362L (CTA→TTA) | korA → | 2‑oxoglutarate oxidoreductase subunit KorA |
| RA | USA300TCH1516_ALE | 1,315,861 | T→C | 5.2% | R381R (CGT→CGC) | korA → | 2‑oxoglutarate oxidoreductase subunit KorA |
| RA | USA300TCH1516_ALE | 1,319,300 | G→A | 5.8% | A478A (GCG→GCA) | miaB → | tRNA‑2‑methylthio‑N(6)‑dimethylallyladenosine synthase |
| RA | USA300TCH1516_ALE | 1,319,376 | A→G | 6.0% | I504V (ATA→GTA) | miaB → | tRNA‑2‑methylthio‑N(6)‑dimethylallyladenosine synthase |
| RA | USA300TCH1516_ALE | 1,331,236 | T→A | 5.2% | S189T (TCT→ACT) | USA300HOU_RS06555 → | Monoacylglycerol lipase |
| RA | USA300TCH1516_ALE | 1,338,620 | G→A | 6.5% | intergenic (+555/‑720) | glnA → / → USA300TCH1516_01240 | Glutamine synthetase/hypothetical protein |
| RA | USA300TCH1516_ALE | 1,338,681 | A→G | 6.6% | intergenic (+616/‑659) | glnA → / → USA300TCH1516_01240 | Glutamine synthetase/hypothetical protein |
| RA | USA300TCH1516_ALE | 1,339,817 | C→A | 9.7% | intergenic (+149/‑145) | USA300HOU_RS06600 → / → USA300HOU_RS06605 | hypothetical protein/hypothetical protein |
| RA | USA300TCH1516_ALE | 1,340,479 | A→T | 5.0% | intergenic (+311/‑928) | USA300HOU_RS06605 → / → USA300HOU_RS06615 | hypothetical protein/hypothetical protein |
| RA | USA300TCH1516_ALE | 1,341,933 | G→A | 5.4% | intergenic (+341/‑171) | USA300HOU_RS06615 → / → USA300TCH1516_01244 | hypothetical protein/hypothetical protein |
| RA | USA300TCH1516_ALE | 1,341,936 | C→A | 5.7% | intergenic (+344/‑168) | USA300HOU_RS06615 → / → USA300TCH1516_01244 | hypothetical protein/hypothetical protein |
| RA | USA300TCH1516_ALE | 1,346,067 | T→C | 5.6% | intergenic (+290/+259) | USA300HOU_RS06685 → / ← ltaE | hypothetical protein/Low specificity L‑threonine aldolase |
| RA | USA300TCH1516_ALE | 1,346,110 | G→C | 5.2% | intergenic (+333/+216) | USA300HOU_RS06685 → / ← ltaE | hypothetical protein/Low specificity L‑threonine aldolase |
| RA | USA300TCH1516_ALE | 1,346,192 | C→T | 5.0% | intergenic (+415/+134) | USA300HOU_RS06685 → / ← ltaE | hypothetical protein/Low specificity L‑threonine aldolase |
| RA | USA300TCH1516_ALE | 1,347,989 | G→A | 5.6% | R38R (AGG→AGA) | cls_1 → | Cardiolipin synthase |
| RA | USA300TCH1516_ALE | 1,353,873 | A→C | 5.1% | intergenic (+66/+77) | nucH → / ← USA300HOU_RS06735 | Thermonuclease/hypothetical protein |
| RA | USA300TCH1516_ALE | 1,354,040 | C→T | 5.7% | S255S (TCG→TCA) | USA300HOU_RS06735 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 1,354,058 | T→G | 5.5% | T249T (ACA→ACC) | USA300HOU_RS06735 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 1,372,042 | A→T | 6.1% | V524V (GTA→GTT) | tkt → | Transketolase |
| RA | USA300TCH1516_ALE | 1,390,631 | T→G | 5.7% | intergenic (+115/‑135) | parC → / → alsT | DNA topoisomerase 4 subunit A/Amino‑acid carrier protein AlsT |
| RA | USA300TCH1516_ALE | 1,416,458 | A→T | 100% | I216N (ATT→AAT) | oppD_4 ← | Oligopeptide transport ATP‑binding protein OppD |
| RA | USA300TCH1516_ALE | 1,429,264 | A→T | 5.5% | L325L (CTA→CTT) | ybiT → | putative ABC transporter ATP‑binding protein YbiT |
| RA | USA300TCH1516_ALE | 1,429,273 | G→A | 5.7% | T328T (ACG→ACA) | ybiT → | putative ABC transporter ATP‑binding protein YbiT |
| RA | USA300TCH1516_ALE | 1,433,241 | A→T | 5.6% | A77A (GCA→GCT) | dapA → | 4‑hydroxy‑tetrahydrodipicolinate synthase |
| RA | USA300TCH1516_ALE | 1,436,255 | T→A | 5.3% | T250T (ACT→ACA) | yxeP_3 → | putative hydrolase YxeP |
| RA | USA300TCH1516_ALE | 1,448,437 | G→A | 5.4% | intergenic (‑14/+15) | USA300HOU_RS07195 ← / ← mhqA_2 | hypothetical protein/Putative ring‑cleaving dioxygenase MhqA |
| RA | USA300TCH1516_ALE | 1,450,291 | G→A | 5.4% | D273D (GAC→GAT) | odhB ← | Dihydrolipoyllysine‑residue succinyltransferase component of 2‑oxoglutarate dehydrogenase complex |
| RA | USA300TCH1516_ALE | 1,451,633 | C→T | 5.7% | A763A (GCG→GCA) | odhA ← | 2‑oxoglutarate dehydrogenase E1 component |
| RA | USA300TCH1516_ALE | 1,451,876 | T→C | 5.9% | A682A (GCA→GCG) | odhA ← | 2‑oxoglutarate dehydrogenase E1 component |
| RA | USA300TCH1516_ALE | 1,460,199 | T→A | 5.1% | intergenic (‑231/+169) | USA300HOU_RS07250 ← / ← USA300HOU_RS07255 | hypothetical protein/putative CtpA‑like serine protease |
| RA | USA300TCH1516_ALE | 1,480,988 | A→C | 5.7% | A7012A (GCT→GCG) | ebh_1 ← | Extracellular matrix‑binding protein ebh |
| RA | USA300TCH1516_ALE | 1,481,732 | C→T | 5.1% | T6764T (ACG→ACA) | ebh_1 ← | Extracellular matrix‑binding protein ebh |
| RA | USA300TCH1516_ALE | 1,489,391 | C→T | 6.2% | P4211P (CCG→CCA) | ebh_1 ← | Extracellular matrix‑binding protein ebh |
| RA | USA300TCH1516_ALE | 1,493,285 | A→T | 5.0% | V2913V (GTT→GTA) | ebh_1 ← | Extracellular matrix‑binding protein ebh |
| RA | USA300TCH1516_ALE | 1,501,244 | A→G | 5.0% | N260N (AAT→AAC) | ebh_1 ← | Extracellular matrix‑binding protein ebh |
| RA | USA300TCH1516_ALE | 1,503,111 | A→G | 5.8% | I234I (ATT→ATC) | norB_4 ← | Quinolone resistance protein NorB |
| RA | USA300TCH1516_ALE | 1,504,140 | T→A | 5.7% | R384R (CGA→CGT) | steT ← | Serine/threonine exchanger SteT |
| RA | USA300TCH1516_ALE | 1,504,143 | T→C | 5.9% | E383E (GAA→GAG) | steT ← | Serine/threonine exchanger SteT |
| RA | USA300TCH1516_ALE | 1,509,367 | C→T | 5.1% | E1008K (GAG→AAG) | USA300HOU_RS07370 ← | Bacterial dynamin‑like protein |
| RA | USA300TCH1516_ALE | 1,512,101 | C→T | 6.7% | T96T (ACG→ACA) | USA300HOU_RS07370 ← | Bacterial dynamin‑like protein |
| RA | USA300TCH1516_ALE | 1,513,930 | A→T | 100% | L413F (TTA→TTT) | USA300HOU_RS07375 → | hypothetical protein |
| RA | USA300TCH1516_ALE | 1,517,372 | C→A | 5.9% | D132Y (GAT→TAT) | USA300HOU_RS07405 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 1,519,965 | A→G | 6.1% | T363T (ACA→ACG) | ponA → | Penicillin‑binding protein 1A/1B |
| RA | USA300TCH1516_ALE | 1,526,104 | C→T | 5.2% | S613S (TCG→TCA) | dinG_1 ← | putative ATP‑dependent helicase DinG |
| RA | USA300TCH1516_ALE | 1,538,398 | T→G | 5.9% | G168G (GGA→GGC) | aroC ← | Chorismate synthase |
| RA | USA300TCH1516_ALE | 1,540,113 | A→G | 6.7% | D11D (GAT→GAC) | ndk ← | Nucleoside diphosphate kinase |
| RA | USA300TCH1516_ALE | 1,550,126 | G→A | 7.0% | I162I (ATC→ATT) | USA300HOU_RS07580 ← | Glucosaminate ammonia‑lyase |
| RA | USA300TCH1516_ALE | 1,550,132 | T→A | 6.7% | V160V (GTA→GTT) | USA300HOU_RS07580 ← | Glucosaminate ammonia‑lyase |
| RA | USA300TCH1516_ALE | 1,622,140 | A→T | 5.0% | T402T (ACA→ACT) | zwf → | Glucose‑6‑phosphate 1‑dehydrogenase |
| RA | USA300TCH1516_ALE | 1,622,149 | C→T | 5.8% | V405V (GTC→GTT) | zwf → | Glucose‑6‑phosphate 1‑dehydrogenase |
| RA | USA300TCH1516_ALE | 1,627,378 | G→T | 5.3% | I365I (ATC→ATA) | gnd ← | 6‑phosphogluconate dehydrogenase, decarboxylating |
| RA | USA300TCH1516_ALE | 1,637,258 | C→T | 5.5% | A432A (GCG→GCA) | recN ← | DNA repair protein RecN |
| RA | USA300TCH1516_ALE | 1,642,186 | G→A | 5.4% | S31S (AGC→AGT) | nusB ← | N utilization substance protein B |
| RA | USA300TCH1516_ALE | 1,646,189 | G→C | 100% | A155G (GCA→GGA) | ypdF ← | Aminopeptidase YpdF |
| RA | USA300TCH1516_ALE | 1,654,418 | G→C | 5.2% | H56Q (CAC→CAG) | USA300HOU_RS08220 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 1,664,318 | T→C | 5.3% | I30V (ATA→GTA) | pbpH ← | Penicillin‑binding protein H |
| RA | USA300TCH1516_ALE | 1,666,504 | A→G | 5.1% | S56S (TCT→TCC) | znuB ← | High‑affinity zinc uptake system membrane protein ZnuB |
| RA | USA300TCH1516_ALE | 1,680,195 | C→T | 5.5% | L96L (TTG→TTA) | cdd ← | Cytidine deaminase |
| RA | USA300TCH1516_ALE | 1,712,214 | G→T | 5.9% | Q150K (CAA→AAA) | mntH_2 ← | Divalent metal cation transporter MntH |
| RA | USA300TCH1516_ALE | 1,740,388 | G→A | 5.4% | L230L (CTA→TTA) | lytC ← | N‑acetylmuramoyl‑L‑alanine amidase LytC |
| RA | USA300TCH1516_ALE | 1,744,473 | C→T | 5.2% | A67T (GCT→ACT) | apt ← | Adenine phosphoribosyltransferase |
| RA | USA300TCH1516_ALE | 1,746,065 | A→T | 5.1% | V301D (GTC→GAC) | recJ ← | Single‑stranded‑DNA‑specific exonuclease RecJ |
| RA | USA300TCH1516_ALE | 1,752,368 | G→A | 5.1% | G276G (GGC→GGT) | ruvB ← | Holliday junction ATP‑dependent DNA helicase RuvB |
| RA | USA300TCH1516_ALE | 1,781,166 | A→G | 5.3% | intergenic (‑138/+58) | infC ← / ← lysP_2 | Translation initiation factor IF‑3/Lysine‑specific permease |
| RA | USA300TCH1516_ALE | 1,789,169 | A→T | 6.0% | V117V (GTT→GTA) | gapA2 ← | Glyceraldehyde‑3‑phosphate dehydrogenase 2 |
| RA | USA300TCH1516_ALE | 1,792,748 | A→T | 8.3% | S367T (TCG→ACG) | polA_2 ← | DNA polymerase I |
| RA | USA300TCH1516_ALE | 1,825,570 | A→T | 5.5% | D70E (GAT→GAA) | tpx ← | putative thiol peroxidase |
| RA | USA300TCH1516_ALE | 1,880,641 | C→A | 6.0% | A1526A (GCG→GCT) | ebh_2 ← | Extracellular matrix‑binding protein ebh |
| RA | USA300TCH1516_ALE | 1,880,650 | A→T | 6.5% | I1523I (ATT→ATA) | ebh_2 ← | Extracellular matrix‑binding protein ebh |
| RA | USA300TCH1516_ALE | 1,880,656 | G→T | 6.5% | R1521R (CGC→CGA) ‡ | ebh_2 ← | Extracellular matrix‑binding protein ebh |
| RA | USA300TCH1516_ALE | 1,880,657 | C→T | 5.8% | R1521H (CGC→CAC) ‡ | ebh_2 ← | Extracellular matrix‑binding protein ebh |
| RA | USA300TCH1516_ALE | 1,880,668 | T→C | 5.5% | E1517E (GAA→GAG) | ebh_2 ← | Extracellular matrix‑binding protein ebh |
| RA | USA300TCH1516_ALE | 1,880,683 | A→T | 5.5% | V1512V (GTT→GTA) | ebh_2 ← | Extracellular matrix‑binding protein ebh |
| RA | USA300TCH1516_ALE | 1,880,716 | G→T | 5.5% | D1501E (GAC→GAA) | ebh_2 ← | Extracellular matrix‑binding protein ebh |
| RA | USA300TCH1516_ALE | 1,921,750 | G→A | 6.0% | G353G (GGC→GGT) | menE ← | 2‑succinylbenzoate‑‑CoA ligase |
| RA | USA300TCH1516_ALE | 1,962,865 | G→A | 5.5% | F91F (TTC→TTT) | ydeN ← | Putative hydrolase YdeN |
| RA | USA300TCH1516_ALE | 1,963,502 | C→T | 6.7% | T453T (ACG→ACA) | hemY ← | Protoporphyrinogen oxidase |
| RA | USA300TCH1516_ALE | 1,997,022 | G→C | 6.2% | noncoding (52/93 nt) | USA300TCH1516_01869 ← | tRNA‑Ser |
| RA | USA300TCH1516_ALE | 2,005,544 | G→A | 5.1% | S40S (AGC→AGT) | ghrB_2 ← | Glyoxylate/hydroxypyruvate reductase B |
| RA | USA300TCH1516_ALE | 2,010,363 | C→T | 100% | C146Y (TGT→TAT) | USA300HOU_RS10125 ← | Putative multidrug export ATP‑binding/permease protein |
| RA | USA300TCH1516_ALE | 2,016,103 | G→A | 5.4% | Y207Y (TAC→TAT) | tagH_2 ← | Teichoic acids export ATP‑binding protein TagH |
| RA | USA300TCH1516_ALE | 2,027,805 | C→A | 5.7% | V48F (GTT→TTT) | vraS ← | Sensor protein VraS |
| RA | USA300TCH1516_ALE | 2,047,465 | A→G | 6.1% | S206P (TCG→CCG) | USA300HOU_RS10335 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,083,000 | G→T | 12.1% | S580* (TCA→TAA) | USA300HOU_RS10525 ← | 65 kDa membrane protein |
| RA | USA300TCH1516_ALE | 2,083,005 | A→T | 9.9% | T578T (ACT→ACA) | USA300HOU_RS10525 ← | 65 kDa membrane protein |
| RA | USA300TCH1516_ALE | 2,102,773 | A→G | 5.1% | intergenic (‑233/+83) | USA300HOU_RS10625 ← / ← USA300HOU_RS10630 | hypothetical protein/hypothetical protein |
| RA | USA300TCH1516_ALE | 2,110,686 | C→T | 5.6% | V23V (GTG→GTA) | USA300HOU_RS10685 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,119,129 | T→C | 5.9% | M369V (ATG→GTG) | smc_4 ← | Chromosome partition protein Smc |
| RA | USA300TCH1516_ALE | 2,119,277 | C→T | 5.6% | T319T (ACG→ACA) | smc_4 ← | Chromosome partition protein Smc |
| RA | USA300TCH1516_ALE | 2,120,582 | C→T | 7.0% | V65I (GTT→ATT) | USA300HOU_RS10785 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,120,625 | A→G | 6.3% | D50D (GAT→GAC) | USA300HOU_RS10785 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,120,639 | A→G | 6.8% | L46L (TTA→CTA) | USA300HOU_RS10785 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,120,664 | G→A | 7.5% | D37D (GAC→GAT) | USA300HOU_RS10785 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,120,669 | G→A | 6.4% | L36L (CTA→TTA) | USA300HOU_RS10785 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,120,673 | A→G | 6.1% | V34V (GTT→GTC) | USA300HOU_RS10785 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,120,676 | C→T | 6.0% | M33I (ATG→ATA) | USA300HOU_RS10785 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,120,685 | G→A | 6.2% | S30S (AGC→AGT) | USA300HOU_RS10785 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,146,840 | A→T | 5.1% | intergenic (+228/+369) | USA300HOU_RS10950 → / ← hld | 2‑oxoglutaramate amidase/Delta‑hemolysin |
| RA | USA300TCH1516_ALE | 2,150,438 | A→G | 5.2% | intergenic (+101/+266) | agrA → / ← scrK | Accessory gene regulator A/Fructokinase |
| RA | USA300TCH1516_ALE | 2,176,264 | A→G | 5.1% | intergenic (+26/+5269) | ilvA → / ← USA300TCH1516_02069 | L‑threonine dehydratase biosynthetic IlvA/tRNA‑Gly |
| RA | USA300TCH1516_ALE | 2,189,877 | G→T | 5.5% | R100R (CGA→AGA) | alr1_2 ← | Alanine racemase 1 |
| RA | USA300TCH1516_ALE | 2,203,709 | T→C | 5.3% | K442K (AAA→AAG) | murF_2 ← | UDP‑N‑acetylmuramoyl‑tripeptide‑‑D‑alanyl‑D‑ alanine ligase |
| RA | USA300TCH1516_ALE | 2,257,055 | C→T | 5.3% | intergenic (‑144/+56) | dps ← / ← USA300HOU_RS11555 | General stress protein 20U/hypothetical protein |
| RA | USA300TCH1516_ALE | 2,279,705 | G→A | 100% | A943V (GCA→GTA) | ebh_3 ← | Extracellular matrix‑binding protein ebh |
| RA | USA300TCH1516_ALE | 2,280,118 | A→T | 6.0% | P805P (CCT→CCA) | ebh_3 ← | Extracellular matrix‑binding protein ebh |
| RA | USA300TCH1516_ALE | 2,282,111 | G→T | 5.4% | T141K (ACA→AAA) | ebh_3 ← | Extracellular matrix‑binding protein ebh |
| RA | USA300TCH1516_ALE | 2,284,800 | T→C | 6.2% | N430D (AAT→GAT) | ebh_4 ← | Extracellular matrix‑binding protein ebh |
| RA | USA300TCH1516_ALE | 2,291,888 | G→A | 7.2% | K813K (AAG→AAA) | USA300HOU_RS11675 → | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,292,012 | T→C | 5.5% | *855R (TGA→CGA) | USA300HOU_RS11675 → | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,292,077 | G→A | 10.8% | intergenic (+63/+167) | USA300HOU_RS11675 → / ← USA300TCH1516_02171 | hypothetical protein/tRNA‑Lys |
| RA | USA300TCH1516_ALE | 2,292,140 | G→A | 5.5% | intergenic (+126/+104) | USA300HOU_RS11675 → / ← USA300TCH1516_02171 | hypothetical protein/tRNA‑Lys |
| RA | USA300TCH1516_ALE | 2,326,699 | A→T | 6.4% | I412K (ATA→AAA) | lacG ← | 6‑phospho‑beta‑galactosidase |
| RA | USA300TCH1516_ALE | 2,326,827 | A→G | 6.1% | H369H (CAT→CAC) | lacG ← | 6‑phospho‑beta‑galactosidase |
| RA | USA300TCH1516_ALE | 2,330,500 | A→G | 5.5% | F161F (TTT→TTC) | lacD ← | Tagatose 1,6‑diphosphate aldolase |
| RA | USA300TCH1516_ALE | 2,337,959 | C→T | 5.2% | intergenic (‑125/‑283) | adhR ← / → USA300HOU_RS11940 | HTH‑type transcriptional regulator AdhR/Hyaluronate lyase |
| RA | USA300TCH1516_ALE | 2,338,218 | G→A | 5.5% | intergenic (‑384/‑24) | adhR ← / → USA300HOU_RS11940 | HTH‑type transcriptional regulator AdhR/Hyaluronate lyase |
| RA | USA300TCH1516_ALE | 2,343,438 | C→T | 6.4% | intergenic (+114/+250) | USA300HOU_RS11955 → / ← aldC_1 | 65 kDa membrane protein/Alpha‑acetolactate decarboxylase |
| RA | USA300TCH1516_ALE | 2,360,177 | G→T | 8.0% | intergenic (‑21/+172) | infA ← / ← adk | Translation initiation factor IF‑1/Adenylate kinase |
| RA | USA300TCH1516_ALE | 2,360,180 | A→T | 8.1% | intergenic (‑24/+169) | infA ← / ← adk | Translation initiation factor IF‑1/Adenylate kinase |
| RA | USA300TCH1516_ALE | 2,372,413 | C→G | 5.8% | intergenic (+164/+28) | USA300TCH1516_02262 → / ← pbuG | hypothetical protein/Guanine/hypoxanthine permease PbuG |
| RA | USA300TCH1516_ALE | 2,372,419 | C→T | 7.3% | intergenic (+170/+22) | USA300TCH1516_02262 → / ← pbuG | hypothetical protein/Guanine/hypoxanthine permease PbuG |
| RA | USA300TCH1516_ALE | 2,379,107 | A→C | 5.1% | V121G (GTT→GGT) | USA300HOU_RS12220 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,379,121 | T→C | 8.3% | G116G (GGA→GGG) | USA300HOU_RS12220 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,379,394 | T→C | 6.7% | K25K (AAA→AAG) | USA300HOU_RS12220 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,391,457 | C→T | 5.4% | A95A (GCG→GCA) | moaE ← | Molybdopterin synthase catalytic subunit |
| RA | USA300TCH1516_ALE | 2,394,482 | T→A | 6.2% | D27V (GAT→GTT) | moaB ← | Molybdenum cofactor biosynthesis protein B |
| RA | USA300TCH1516_ALE | 2,413,192 | C→A | 5.4% | S516S (TCG→TCT) ‡ | nphR ← | Transcriptional activator NphR |
| RA | USA300TCH1516_ALE | 2,413,194 | A→C | 5.6% | S516A (TCG→GCG) ‡ | nphR ← | Transcriptional activator NphR |
| RA | USA300TCH1516_ALE | 2,413,260 | A→T | 5.2% | S494T (TCT→ACT) | nphR ← | Transcriptional activator NphR |
| RA | USA300TCH1516_ALE | 2,413,272 | T→A | 5.1% | I490F (ATT→TTT) | nphR ← | Transcriptional activator NphR |
| RA | USA300TCH1516_ALE | 2,427,156 | T→G | 5.2% | R342R (CGA→CGC) | USA300HOU_RS12500 ← | Putative formate dehydrogenase |
| RA | USA300TCH1516_ALE | 2,474,769 | C→T | 6.0% | intergenic (‑165/+104) | bcr_1 ← / ← tcaA | Bicyclomycin resistance protein/Membrane‑associated protein TcaA |
| RA | USA300TCH1516_ALE | 2,479,526 | A→G | 5.3% | G108G (GGT→GGC) | hrtA_2 ← | Putative hemin import ATP‑binding protein HrtA |
| RA | USA300TCH1516_ALE | 2,524,206 | A→C | 5.0% | A142A (GCT→GCG) | nasD ← | Nitrite reductase [NAD(P)H] |
| RA | USA300TCH1516_ALE | 2,525,787 | A→T | 10.0% | I136I (ATT→ATA) | ytmI ← | putative N‑acetyltransferase YtmI |
| RA | USA300TCH1516_ALE | 2,528,064 | C→T | 5.6% | V46V (GTG→GTA) | USA300TCH1516_02412 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,528,070 | G→T | 5.9% | T44T (ACC→ACA) | USA300TCH1516_02412 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,528,073 | A→G | 5.5% | S43S (AGT→AGC) | USA300TCH1516_02412 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,528,079 | G→C | 6.3% | D41E (GAC→GAG) ‡ | USA300TCH1516_02412 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,528,080 | T→C | 6.4% | D41G (GAC→GGC) ‡ | USA300TCH1516_02412 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,528,110 | G→T | 7.1% | A31E (GCA→GAA) | USA300TCH1516_02412 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,530,786 | A→G | 5.2% | intergenic (‑37/+236) | yefM ← / ← bdbD | Antitoxin YefM/Disulfide bond formation protein D |
| RA | USA300TCH1516_ALE | 2,532,298 | A→T | 100% | T15T (ACA→ACT) | femA_3 → | Aminoacyltransferase FemA |
| RA | USA300TCH1516_ALE | 2,559,032 | T→A | 6.3% | V146V (GTT→GTA) | bcr_2 → | Bicyclomycin resistance protein |
| RA | USA300TCH1516_ALE | 2,559,065 | C→T | 5.3% | A157A (GCC→GCT) | bcr_2 → | Bicyclomycin resistance protein |
| RA | USA300TCH1516_ALE | 2,559,840 | T→G | 9.0% | intergenic (+34/+89) | bcr_2 → / ← USA300HOU_RS13190 | Bicyclomycin resistance protein/hypothetical protein |
| RA | USA300TCH1516_ALE | 2,559,841 | C→A | 8.5% | intergenic (+35/+88) | bcr_2 → / ← USA300HOU_RS13190 | Bicyclomycin resistance protein/hypothetical protein |
| RA | USA300TCH1516_ALE | 2,559,850 | T→C | 8.8% | intergenic (+44/+79) | bcr_2 → / ← USA300HOU_RS13190 | Bicyclomycin resistance protein/hypothetical protein |
| RA | USA300TCH1516_ALE | 2,559,851 | C→T | 8.3% | intergenic (+45/+78) | bcr_2 → / ← USA300HOU_RS13190 | Bicyclomycin resistance protein/hypothetical protein |
| RA | USA300TCH1516_ALE | 2,622,662 | A→G | 5.3% | Y3Y (TAT→TAC) | USA300HOU_RS13520 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,642,644 | T→A | 5.1% | intergenic (‑74/+65) | USA300HOU_RS13595 ← / ← yccS | hypothetical protein/Inner membrane protein YccS |
| RA | USA300TCH1516_ALE | 2,654,172 | T→A | 5.0% | G145G (GGT→GGA) | USA300HOU_RS13650 → | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,654,178 | C→T | 5.4% | T147T (ACC→ACT) | USA300HOU_RS13650 → | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,668,042 | A→G | 5.3% | Y50Y (TAT→TAC) | USA300HOU_RS13735 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,691,962 | G→A | 5.3% | F225F (TTC→TTT) | ydfJ ← | Membrane protein YdfJ |
| RA | USA300TCH1516_ALE | 2,696,979 | G→A | 6.1% | D98N (GAC→AAC) | copA → | Copper‑exporting P‑type ATPase A |
| RA | USA300TCH1516_ALE | 2,716,934 | T→C | 6.8% | T96A (ACA→GCA) | USA300HOU_RS13970 ← | hypothetical protein |
| RA | USA300TCH1516_ALE | 2,721,481 | T→C | 8.7% | L198S (TTA→TCA) | USA300HOU_RS14000 → | putative hydrolase |
| RA | USA300TCH1516_ALE | 2,721,513 | A→G | 7.0% | N209D (AAT→GAT) | USA300HOU_RS14000 → | putative hydrolase |
| RA | USA300TCH1516_ALE | 2,763,245 | T→A | 5.1% | V265V (GTA→GTT) | cysJ ← | Sulfite reductase [NADPH] flavoprotein alpha‑component |
| RA | USA300TCH1516_ALE | 2,774,930 | C→T | 7.5% | S752S (TCG→TCA) | clfB ← | Clumping factor B |
| RA | USA300TCH1516_ALE | 2,774,981 | A→G | 6.3% | D735D (GAT→GAC) | clfB ← | Clumping factor B |
| RA | USA300TCH1516_ALE | 2,775,041 | A→G | 6.9% | D715D (GAT→GAC) | clfB ← | Clumping factor B |
| RA | USA300TCH1516_ALE | 2,831,977 | G→T | 8.6% | Q230K (CAA→AAA) | lipA_2 ← | Lipase 1 |
| RA | USA300TCH1516_ALE | 2,833,850 | A→T | 6.0% | L179L (CTT→CTA) | hisI ← | Phosphoribosyl‑AMP cyclohydrolase |
| RA | USA300TCH1516_ALE | 2,848,983 | C→T | 5.1% | intergenic (‑169/‑72) | USA300HOU_RS14590 ← / → moeZ_3 | Lactonase drp35/putative adenylyltransferase/sulfurtransferase MoeZ |
| RA | USA300TCH1516_ALE | 2,867,125 | A→G | 5.7% | L257L (TTA→CTA) | noc_2 ← | Nucleoid occlusion protein |
| Unassigned new junction evidence | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
| * | ? | CP000731 | = 16959 | NA (NA) | 11 (0.050) | 6/232 | NT | 6.8% | coding (103/675 nt) | USA300HOU_pUSA300HOUMR0021 | IS431 mec transposase |
| ? | CP000731 | = 17055 | 167 (0.660) | coding (7/675 nt) | USA300HOU_pUSA300HOUMR0021 | IS431 mec transposase | |||||
| * | ? | NC_012417 | = 3069 | 998 (0.320) | 26 (0.010) | 16/244 | NT | 5.2% | intergenic (‑395/–) | USA300HOU_RS14900/– | hypothetical protein/– |
| ? | NC_012417 | = 3118 | 0 (0.000) | intergenic (‑444/–) | USA300HOU_RS14900/– | hypothetical protein/– | |||||
| * | ? | USA300TCH1516_ALE | 62771 = | 31 (0.250) | 9 (0.080) | 5/240 | NT | 34.1% | intergenic (‑238/+275) | USA300TCH1516_00053/speG | hypothetical protein/Spermidine N(1)‑acetyltransferase |
| ? | USA300TCH1516_ALE | 62827 = | 6 (0.050) | intergenic (‑294/+219) | USA300TCH1516_00053/speG | hypothetical protein/Spermidine N(1)‑acetyltransferase | |||||
| * | ? | USA300TCH1516_ALE | = 399701 | 113 (0.910) | 6 (0.050) | 6/236 | NT | 5.4% | intergenic (+9/+83) | efeU/tatC2 | Ferrous iron permease EfeU/Sec‑independent protein translocase protein TatCy |
| ? | USA300TCH1516_ALE | = 399706 | 108 (0.950) | intergenic (+14/+78) | efeU/tatC2 | Ferrous iron permease EfeU/Sec‑independent protein translocase protein TatCy | |||||
| * | ? | USA300TCH1516_ALE | 512620 = | 151 (1.210) | 97 (1.130) +40 bp |
68/178 | NT | 48.2% | intergenic (+688/‑6075) | recR/speA_2 | Recombination protein RecR/Arginine decarboxylase |
| ? | USA300TCH1516_ALE | 1998278 = | NA (NA) | intergenic (‑6/+3329) | USA300TCH1516_01882/USA300TCH1516_01883 | tRNA‑Val/tRNA‑Ala | |||||
| * | ? | USA300TCH1516_ALE | = 514610 | NA (NA) | 6 (0.050) | 6/244 | NT | 23.2% | intergenic (+2678/‑4085) | recR/speA_2 | Recombination protein RecR/Arginine decarboxylase |
| ? | USA300TCH1516_ALE | = 558903 | 21 (0.170) | intergenic (+116/+3686) | USA300TCH1516_00505/gabR | tRNA‑Ile/HTH‑type transcriptional regulatory protein GabR | |||||
| * | ? | USA300TCH1516_ALE | 514644 = | NA (NA) | 11 (0.090) +TGG |
3/252 | NT | 79.0% | intergenic (+2712/‑4051) | recR/speA_2 | Recombination protein RecR/Arginine decarboxylase |
| ? | USA300TCH1516_ALE | 558945 = | 3 (0.020) | intergenic (+158/+3644) | USA300TCH1516_00505/gabR | tRNA‑Ile/HTH‑type transcriptional regulatory protein GabR | |||||
| * | ? | USA300TCH1516_ALE | = 515946 | NA (NA) | 6 (0.050) | 4/244 | NT | NA | intergenic (+4014/‑2749) | recR/speA_2 | Recombination protein RecR/Arginine decarboxylase |
| ? | USA300TCH1516_ALE | = 515981 | NA (NA) | intergenic (+4049/‑2714) | recR/speA_2 | Recombination protein RecR/Arginine decarboxylase | |||||
| * | ? | USA300TCH1516_ALE | = 517080 | NA (NA) | 5 (0.040) | 5/250 | NT | NA | intergenic (+5148/‑1615) | recR/speA_2 | Recombination protein RecR/Arginine decarboxylase |
| ? | USA300TCH1516_ALE | = 517096 | NA (NA) | intergenic (+5164/‑1599) | recR/speA_2 | Recombination protein RecR/Arginine decarboxylase | |||||
| * | ? | USA300TCH1516_ALE | 802131 = | 110 (0.880) | 6 (0.050) | 5/236 | NT | 5.7% | intergenic (+372/+252) | USA300HOU_RS03915/USA300HOU_RS03920 | Putative 5'(3')‑deoxyribonucleotidase/Putative lipid kinase |
| ? | USA300TCH1516_ALE | 802180 = | 97 (0.850) | intergenic (+421/+203) | USA300HOU_RS03915/USA300HOU_RS03920 | Putative 5'(3')‑deoxyribonucleotidase/Putative lipid kinase | |||||
| * | ? | USA300TCH1516_ALE | = 932471 | 121 (0.970) | 7 (0.060) | 7/234 | NT | 5.7% | intergenic (+17/+246) | USA300HOU_RS04635/nfuA | hypothetical protein/Fe/S biogenesis protein NfuA |
| ? | USA300TCH1516_ALE | = 932493 | 120 (1.060) | intergenic (+39/+224) | USA300HOU_RS04635/nfuA | hypothetical protein/Fe/S biogenesis protein NfuA | |||||
| * | ? | USA300TCH1516_ALE | = 1205323 | 119 (0.960) | 50 (0.570) +38 bp |
11/182 | NT | 37.7% | intergenic (‑204/‑365) | USA300HOU_RS15290/lspA | hypothetical protein/Lipoprotein signal peptidase |
| ? | USA300TCH1516_ALE | 2478252 = | 115 (0.920) | intergenic (+139/‑436) | USA300HOU_RS12760/USA300HOU_RS12765 | hypothetical protein/hypothetical protein | |||||
| * | ? | USA300TCH1516_ALE | 1575673 = | 107 (0.860) | 7 (0.060) | 5/248 | NT | 6.4% | coding (1844/6201 nt) | USA300HOU_RS07705 | Glycyl‑glycine endopeptidase ALE‑1 |
| ? | USA300TCH1516_ALE | 1575710 = | 102 (0.850) | coding (1807/6201 nt) | USA300HOU_RS07705 | Glycyl‑glycine endopeptidase ALE‑1 | |||||
| * | ? | USA300TCH1516_ALE | 1619594 = | 96 (0.770) | 6 (0.050) | 5/244 | NT | 5.9% | coding (813/816 nt) | proC | Pyrroline‑5‑carboxylate reductase |
| ? | USA300TCH1516_ALE | 1619661 = | 102 (0.870) | intergenic (+64/+41) | proC/rnz | Pyrroline‑5‑carboxylate reductase/Ribonuclease Z | |||||
| * | ? | USA300TCH1516_ALE | 1822865 = | 129 (1.040) | 7 (0.060) | 7/240 | NT | 5.7% | intergenic (+186/+60) | USA300HOU_RS09070/ackA | Putative universal stress protein/Acetate kinase |
| ? | USA300TCH1516_ALE | 1822909 = | 110 (0.950) | intergenic (+230/+16) | USA300HOU_RS09070/ackA | Putative universal stress protein/Acetate kinase | |||||
| * | ? | USA300TCH1516_ALE | 1838254 = | 133 (1.070) | 6 (0.050) | 6/238 | NT | 5.1% | intergenic (‑58/+49) | gph_2/nagE | Phosphoglycolate phosphatase/PTS system N‑acetylglucosamine‑specific EIICBA component |
| ? | USA300TCH1516_ALE | 1838290 = | 100 (0.870) | intergenic (‑94/+13) | gph_2/nagE | Phosphoglycolate phosphatase/PTS system N‑acetylglucosamine‑specific EIICBA component | |||||
| * | ? | USA300TCH1516_ALE | = 1878614 | 108 (0.870) | 7 (0.070) | 5/222 | NT | 6.3% | intergenic (+73/+44) | USA300HOU_RS09320/ebh_2 | Ferredoxin‑‑NADP reductase/Extracellular matrix‑binding protein ebh |
| ? | USA300TCH1516_ALE | = 1878633 | 114 (1.060) | intergenic (+92/+25) | USA300HOU_RS09320/ebh_2 | Ferredoxin‑‑NADP reductase/Extracellular matrix‑binding protein ebh | |||||
| * | ? | USA300TCH1516_ALE | 1994322 = | NA (NA) | 3 (0.030) | 3/246 | NT | 18.3% | intergenic (‑429/‑64) | USA300HOU_RS09935/USA300HOU_RS11675 | hypothetical protein/hypothetical protein |
| ? | USA300TCH1516_ALE | 1994387 = | 14 (0.110) | coding (2/1362 nt) | USA300HOU_RS11675 | hypothetical protein | |||||
| * | ? | USA300TCH1516_ALE | 2248208 = | 134 (1.080) | 8 (0.070) | 8/248 | NT | 6.0% | intergenic (+2/+128) | coaW/USA300HOU_RS11505 | Type II pantothenate kinase/hypothetical protein |
| ? | USA300TCH1516_ALE | 2248263 = | 121 (1.010) | intergenic (+57/+73) | coaW/USA300HOU_RS11505 | Type II pantothenate kinase/hypothetical protein | |||||
| * | ? | USA300TCH1516_ALE | 2336425 = | 108 (0.870) | 8 (0.070) | 8/236 | NT | 8.1% | intergenic (‑145/+75) | USA300HOU_RS11920/USA300HOU_RS11925 | hypothetical protein/putative oxidoreductase/MSMEI_2347 |
| ? | USA300TCH1516_ALE | 2336465 = | 83 (0.730) | intergenic (‑185/+35) | USA300HOU_RS11920/USA300HOU_RS11925 | hypothetical protein/putative oxidoreductase/MSMEI_2347 | |||||
| * | ? | USA300TCH1516_ALE | 2661788 = | 121 (0.970) | 6 (0.050) | 6/226 | NT | 5.9% | intergenic (‑181/‑140) | ybiV/yydI | Sugar phosphatase YbiV/putative peptide export ATP‑binding protein YydI |
| ? | USA300TCH1516_ALE | 2661832 = | 85 (0.780) | intergenic (‑225/‑96) | ybiV/yydI | Sugar phosphatase YbiV/putative peptide export ATP‑binding protein YydI | |||||